IRBM signed agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
MouseLight Project mapped 1,000 neurons in the mouse brain
On Sept. 5, 2019, researchers at the Howard Hughes Medical Instituteﾒs Janelia Research Campus announced that they had…
Penn researcher Virginia MY Lee, PhD, received $3 million Breakthrough Prize
On Sept. 5, 2019, Penn Professor Virginia M.Y. Lee, PhD received the Breakthrough Prize in Life Sciences, in…
University of Alberta researchers discovered the protein PEX3 in the cells of deadly parasite trypanosome
On Aug. 26, 2019, University of Alberta researcher Rick Rachubinski and colleagues announced they had discovered the protein…
City of Port St Lucie Council voted to ﾠLeaseﾠ former VGTI Florida facility to the ﾠCleveland Clinic for $1 per year
On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ﾠleaseﾠ…
CDC released ACIP recommendations on use of influenza vaccines for the 2019-20 influenza season
On Aug. 23, 2019, the Centers for Disease Control and Prevention (CDC) released Immunization Practices Advisory Committee (ACIP)…
Siteman Cancer Center received $15 million grant to support personalized leukemia therapies
On Aug. 21, 2019, the Siteman Cancer Center announced it was awarded a $15 million grant to better…
Karmanos Cancer Institute became the first in Michigan to offer patients the Leksell Gamma Knife Icon stereotactic radiosurgery system
On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…
CDC published updated ACIP recommendations for human papillomavirus vaccination of adults
On Aug. 16, 2019, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
Masonic Cancer Center researchers awarded $8.5 million dollar grant to research metastatic breast cancer
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
Biotechnology | Disease | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Therapeutics
CPRIT granted $18.7 million New Company Product Development award to Salarius Pharmaceuticals
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
Siteman Cancer Center awarded $7.8 million to expand clinical trials access
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
Sylvester Comprehensive Cancer Center announced it had received NCI designation
On Jul. 29, 2019, Sylvester Comprehensive Cancer Center announced it had achieved National Cancer Institute (NCI) designation, becoming…
Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA repair pathway
On Jul. 25, 2019, Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA…
More than 5,000 lives touched by OHSU Kidney Transplant Program
On Jul. 24, 2019, the Oregon Health Science University (OHSU) Transplant Program – one of the oldest, largest…
CDC published ACIP recommendations on use of Japanese encephalitis vaccine
On Jul. 19, 2019, the Centers for Disease Control and Prevention (CDC) published recommendations from the Advisory Committee…
Masonic Cancer Center member Ingunn Stromnes, PhD awarded with PanCAN Grant
On Jul. 9, 2019, the Masonic Cancer Center announced that researcher Ingunn Stromnes, PhD was awarded with a…
Vanderbilt Vaccine Center Director James Crow Jr, MD, was awarded half of the Future Insight Prize by Merck KGaA of Germany
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
DARPA funded a $21.9 gene modulation research initiative at Georgia Tech, targeting influenza pandemics
In Jun. 2019, Defense Advanced Research Projects Agency (DARPA) announced it had funded a $21.9 gene modulation research…
Columbia Sportswear’s Tim and Mary Boyle announced a $10 million gift to OHSU Knight Cancer Institute
On Jun. 18, 2019, Columbia Sportswear President and CEO Tim Boyle and his wife, Mary, announced a donation…
the largest stock of the rinderpest virus was destroyed at the Pirbright Institute.
On Jun. 14, 2019, the Pirbright Institute announced that it had destroyed the last samples of rinderpest virus…
New CRISPR Lab for Genomic Research at UCSF and UC Berkeley in collaboratation with GlaxoSmithKline
On Jun. 13, 2019, the University of California, San Francisco and University of California, Berkeley collaborated with GlaxoSmithKline…
Groundbreaking DNA study launched to discover new connections between genetics & diseases
On Jun. 12, 2019, Intermountain Healthcare and deCODE genetics announced a major global collaboration and study focused on…
Penn received a $12 million grant to study the connection between cellular therapies and new methods of radiation therapy
On Jun. 3, 2019, the University of Pennsylvania (Penn) announced it had received a $12 million grant from…
The Richard N Merkin Institute for Translational Research was founded at CalTech
On May 30, 2019, The Richard N. Merkin Institute for Translational Research was founded at CalTech. Merkin, who…
Masonic Cancer Center researchers discovered importance of protein p300 acetyltransferase in liver cancer development
On May 3, 2019, Masonic Cancer Center researcher Dr. Ningling Kang and colleauges at The Hormel Institute announced…
Massachusetts General Hospital received $200 million to advance research into complex diseases
On Apr. 29, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…
St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease
On Apr. 18, 2019, St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease. By…
The only FDA approved IV antimalarial in the US, IV quinidine, was discontinued
In Mar. 29, 2019, the Centers for Disease Control and Prevention (CDC) issued new guidance to clinicians for…